| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M909741199 |
| P698 | PubMed publication ID | 10748157 |
| P2093 | author name string | Q Gu | |
| Y Wu | |||
| J Lee | |||
| D Dowbenko | |||
| L A Lasky | |||
| S Spencer | |||
| R Laura | |||
| P2860 | cites work | The lipid phosphatase activity of PTEN is critical for its tumor supressor function | Q22007981 |
| The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region | Q22010498 | ||
| Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins | Q24310521 | ||
| Cloning and characterization of BAI-associated protein 1: a PDZ domain-containing protein that interacts with BAI1 | Q24310654 | ||
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| A novel multiple PDZ domain-containing molecule interacting with N-methyl-D-aspartate receptors and neuronal cell adhesion proteins | Q24321831 | ||
| Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN | Q24322051 | ||
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions | Q24672971 | ||
| PSTPIP: a tyrosine phosphorylated cleavage furrow-associated protein that is a substrate for a PEST tyrosine phosphatase | Q24679587 | ||
| Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association | Q27620298 | ||
| Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ | Q27732927 | ||
| Crystal structure of a PDZ domain | Q27733300 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density | Q28235849 | ||
| PDZ domains: targeting signalling molecules to sub-membranous sites | Q28242408 | ||
| MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains | Q28256306 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Pten is essential for embryonic development and tumour suppression | Q28509238 | ||
| Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 | ||
| Recognition of unique carboxyl-terminal motifs by distinct PDZ domains | Q29547580 | ||
| Organizing a functional junctional complex requires specific domains of the Drosophila MAGUK Discs large | Q30176301 | ||
| PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells | Q33586807 | ||
| The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway | Q33599964 | ||
| Inhibition of patterned cell shape change and cell invasion by Discs large during Drosophila oogenesis | Q35192400 | ||
| The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells | Q35574865 | ||
| Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression | Q36067596 | ||
| Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways | Q36256326 | ||
| In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma | Q36260162 | ||
| Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain | Q36818855 | ||
| Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction | Q40957062 | ||
| Protein-protein interactions: PDZ domain networks | Q41238394 | ||
| PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond | Q41596068 | ||
| Ion channel targeting in neurons | Q41639258 | ||
| Mechanisms and consequences of activation of protein kinase B/Akt | Q41751003 | ||
| Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. | Q42824933 | ||
| PTEN: sometimes taking it off can be better than putting it on. | Q43104730 | ||
| PDZ proteins organize synaptic signaling pathways | Q46332824 | ||
| A multivalent PDZ-domain protein assembles signalling complexes in a G-protein-coupled cascade | Q47070943 | ||
| PTEN and inherited hamartoma-cancer syndromes | Q47852476 | ||
| Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain | Q48317594 | ||
| Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. | Q52176221 | ||
| High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice | Q58378937 | ||
| P433 | issue | 28 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intracellular signal transduction | Q14851952 |
| Membrane associated guanylate kinase, WW and PDZ domain containing 3 | Q21112534 | ||
| P304 | page(s) | 21477-85 | |
| P577 | publication date | 2000-07-14 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase | |
| P478 | volume | 275 |
| Q39376108 | A functional network of the tumor suppressors APC, hDlg, and PTEN, that relies on recognition of specific PDZ-domains. |
| Q34236641 | A new role for PTEN in regulating transient receptor potential canonical channel 6-mediated Ca2+ entry, endothelial permeability, and angiogenesis |
| Q30442233 | A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer |
| Q103826227 | Activation of PAR2 by tissue factor induces the release of the PTEN from MAGI proteins and regulates PTEN and Akt activities |
| Q38827214 | Adherens Junction and E-Cadherin complex regulation by epithelial polarity. |
| Q39004694 | Adhesion GPCR-Related Protein Networks |
| Q42508293 | Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis |
| Q36283583 | Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein |
| Q55053616 | Alpha-1-syntrophin protein is differentially expressed in human cancers |
| Q37431681 | Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex |
| Q35035153 | Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells |
| Q34624331 | Architecture of tight junctions and principles of molecular composition |
| Q37270429 | Assessment of PTEN tumor suppressor activity in nonmammalian models: the year of the yeast. |
| Q24305156 | Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases |
| Q48506104 | Biochemical and morphological characterization of MAGI-1 in neuronal tissue |
| Q24338648 | CIN85 is localized at synapses and forms a complex with S-SCAM via dendrin |
| Q33340425 | Cell adhesion, polarity, and epithelia in the dawn of metazoans. |
| Q37749618 | Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions. |
| Q40058784 | Cellular localization of MAGI-1 caspase cleavage products and their role in apoptosis |
| Q36313163 | Class reunion: PTEN joins the nuclear crew. |
| Q36244220 | Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer |
| Q41515187 | Cleavage of MAGI-1, a tight junction PDZ protein, by caspases is an important step for cell-cell detachment in apoptosis |
| Q24653987 | Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 |
| Q39640839 | Comparison of p53 and the PDZ domain containing protein MAGI-3 regulation by the E6 protein from high-risk human papillomaviruses |
| Q24673801 | Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation |
| Q43152647 | Drosophila MAGI interacts with RASSF8 to regulate E-Cadherin-based adherens junctions in the developing eye. |
| Q34963137 | Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is regulated by an N-terminal phosphorylation site |
| Q40512855 | Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts |
| Q37866083 | Epithelial cell polarity and tumorigenesis: new perspectives for cancer detection and treatment |
| Q45071481 | Evolution of metazoan cell junction proteins: the scaffold protein MAGI and the transmembrane receptor tetraspanin in the demosponge Suberites domuncula |
| Q24297954 | Expression of AIE-75 PDZ-domain protein induces G2/M cell cycle arrest in human colorectal adenocarcinoma SW480 cells |
| Q26797287 | Focus on PTEN Regulation |
| Q33657578 | Gene expression profile of androgen modulated genes in the murine fetal developing lung |
| Q33730559 | Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease |
| Q28360379 | HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation |
| Q40513963 | HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation |
| Q53118756 | Hematopoietic Stem Cell Activity Is Regulated by Pten Phosphorylation Through a Niche-Dependent Mechanism. |
| Q35261245 | Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis |
| Q37333627 | Human papillomaviruses, cervical cancer and cell polarity |
| Q24307775 | Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1 |
| Q24338166 | Identification of MAGI-3 as a transforming growth factor-alpha tail binding protein |
| Q58994624 | Identification of PDZ Domain Containing Proteins Interacting with 1.2 and PMCA4b |
| Q35105700 | Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease |
| Q55515829 | In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself. |
| Q28202074 | Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1 |
| Q44088646 | Investigation of the PDZ domain ligand binding site using chemically modified peptides. |
| Q33546201 | Isolation of putative FOXO1 genomic elements using an improved in vitro technique to isolate genomic regulatory sequences |
| Q28208782 | JEAP, a novel component of tight junctions in exocrine cells |
| Q38275382 | Kinases, tails and more: regulation of PTEN function by phosphorylation |
| Q35895719 | Large-scale phosphotyrosine proteomic profiling of rat renal collecting duct epithelium reveals predominance of proteins involved in cell polarity determination |
| Q35096682 | Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial |
| Q53390981 | Loss of tumor suppressor protein PTEN during renal carcinogenesis. |
| Q37194251 | Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect |
| Q27354851 | MAGI-1 modulates AMPA receptor synaptic localization and behavioral plasticity in response to prior experience |
| Q24294392 | MAGI-2 Inhibits cell migration and proliferation via PTEN in human hepatocarcinoma cells |
| Q90292063 | MAGI-2 downregulation: a potential predictor of tumor progression and early recurrence in Han Chinese patients with prostate cancer |
| Q34384101 | MAGI-2 scaffold protein is critical for kidney barrier function |
| Q34672741 | MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells. |
| Q28266828 | MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap |
| Q24680474 | MAGI-3 regulates LPA-induced activation of Erk and RhoA |
| Q28252176 | MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface |
| Q38338534 | MAGI2/S-SCAM outside brain |
| Q36546491 | MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells. |
| Q37220171 | MC1R is a potent regulator of PTEN after UV exposure in melanocytes |
| Q31044207 | Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data |
| Q24290802 | Membrane-associated guanylate kinase with inverted orientation (MAGI)-1/brain angiogenesis inhibitor 1-associated protein (BAP1) as a scaffolding molecule for Rap small G protein GDP/GTP exchange protein at tight junctions |
| Q35145882 | Membrane-binding and activation mechanism of PTEN. |
| Q38475375 | Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells |
| Q38313393 | Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils |
| Q43955971 | Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity |
| Q28203316 | Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule |
| Q28210051 | Multifunctional strands in tight junctions |
| Q50627780 | Mutations modifying sporadic Alzheimer's disease age of onset. |
| Q35256204 | NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN. |
| Q28592252 | Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells |
| Q40594378 | Nectin-dependent localization of synaptic scaffolding molecule (S-SCAM) at the puncta adherentia junctions formed between the mossy fibre terminals and the dendrites of pyramidal cells in the CA3 area of the mouse hippocampus |
| Q35548957 | Nitric Oxide/Nitric Oxide Synthase, Spermatogenesis, and Tight Junction Dynamics1 |
| Q36032452 | Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo |
| Q42218359 | Nongenomic Mechanisms of PTEN Regulation |
| Q28242514 | Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis |
| Q28564702 | Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs |
| Q34141231 | Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation |
| Q57083899 | PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors |
| Q41895077 | PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo |
| Q80098185 | PDZ-domain arrays for identifying components of GPCR signaling complexes |
| Q33940647 | PTEN 2, a Golgi-associated testis-specific homologue of the PTEN tumor suppressor lipid phosphatase |
| Q28218655 | PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease |
| Q34180652 | PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench |
| Q28217868 | PTEN associates with the vault particles in HeLa cells |
| Q24528114 | PTEN function: how normal cells control it and tumour cells lose it |
| Q38198345 | PTEN function: the long and the short of it. |
| Q26995513 | PTEN modulators: a patent review |
| Q48066104 | PTEN recruitment controls synaptic and cognitive function in Alzheimer's models. |
| Q24303571 | PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling |
| Q42911804 | PTEN, here, there, everywhere |
| Q37955889 | PTEN-Associated Complexes: An Overview. |
| Q38275375 | PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13. |
| Q34540849 | PTEN: The down side of PI 3-kinase signalling. |
| Q28572470 | Par-3-mediated junctional localization of the lipid phosphatase PTEN is required for cell polarity establishment |
| Q64896387 | Phenotypic expansion illuminates multilocus pathogenic variation. |
| Q37308049 | Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles |
| Q33862413 | Phosphoinositide phosphatases in cell biology and disease |
| Q34101673 | Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex |
| Q47588393 | Phosphorylation of tight junction transmembrane proteins: Many sites, much to do. |
| Q44467149 | Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implications for the control of protein stability and PTEN-protein interactions |
| Q24291796 | Pilt, a novel peripheral membrane protein at tight junctions in epithelial cells |
| Q24304037 | Postsynaptic recruitment of Dendrin depends on both dendritic mRNA transport and synaptic anchoring |
| Q24613810 | Protean PTEN: form and function |
| Q24297397 | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins |
| Q36943536 | Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity |
| Q34707865 | Pten signaling in gliomas |
| Q36266420 | Redox regulation of PI 3-kinase signalling via inactivation of PTEN |
| Q29977747 | Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. |
| Q36951961 | Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions |
| Q36410968 | Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein |
| Q34032470 | Sequence analysis of mutations and translocations across breast cancer subtypes |
| Q35073616 | Sertoli cell tight junction dynamics: their regulation during spermatogenesis |
| Q94601753 | Shear Stress Triggers Angiogenesis of Late Endothelial Progenitor Cells via the PTEN/Akt/GTPCH/BH4 Pathway |
| Q34180670 | Signalling to and from tight junctions |
| Q50436009 | Somatic PI3K activity regulates transition to the spermatocyte stages in Drosophila testis. |
| Q40557650 | Suppression of a phosphatidylinositol 3-kinase signal by a specific spliced variant of Drosophila PTEN. |
| Q57364534 | Synergy in tumor suppression by direct interaction of Neutral Endopeptidase with PTEN |
| Q37223362 | Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase |
| Q28343581 | Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions |
| Q36539868 | Targeting protein-protein interactions by rational design: mimicry of protein surfaces |
| Q28217069 | The Erbin PDZ domain binds with high affinity and specificity to the carboxyl termini of delta-catenin and ARVCF |
| Q36832696 | The N and C termini of ZO-1 are surrounded by distinct proteins and functional protein networks |
| Q40507359 | The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells |
| Q37333603 | The epithelial polarity program: machineries involved and their hijacking by cancer. |
| Q88955683 | The functions and regulation of the PTEN tumour suppressor: new modes and prospects |
| Q34468780 | The human papillomavirus E6 protein and its contribution to malignant progression |
| Q81241238 | The human tumour suppressor PTEN regulates longevity and dauer formation in Caenorhabditis elegans |
| Q34103481 | The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis |
| Q35777543 | The tight junction: a multifunctional complex |
| Q24290417 | The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation |
| Q37420725 | Tight junctions: a barrier to the initiation and progression of breast cancer? |
| Q36400271 | Tight junctions: molecular architecture and function |
| Q33112683 | Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor |
| Q24291617 | beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95 |
Search more.